SCHEMBL5460397

SCHEMBL5460397

COc1ccc(Cn2ccc3c(Cl)ncnc32)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.57
BCR P11274 1/20 0.57
LMNA P02545 3/20 0.52
ALDH1A1 P00352 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
BMPR1B O00238 3/20 0.48
ACVR1B P36896 3/20 0.48
TGFBR1 P36897 3/20 0.48
ACVRL1 P37023 3/20 0.48
ACVR1 Q04771 3/20 0.48
BMPR1A P36894 1/20 0.48
FGFR1 P11362 1/20 0.47
FGFR4 P22455 1/20 0.47
HPGD P15428 1/20 0.45
TPH1 P17752 1/20 0.44
MAPT P10636 3/20 0.43
TP53 P04637 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
HTT P42858 1/20 0.41
NOTUM Q6P988 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29246485 0.89 ABL1 (0.47) ABL1BCRLMNAALDH1A1SMN1; SMN2
SCHEMBL29246271 0.86 LPO (0.51) ABL1BCRLMNAALDH1A1SMN1; SMN2
SCHEMBL30910333 0.86 LPO (0.51) ABL1BCRLMNAALDH1A1SMN1; SMN2
SCHEMBL9046752 0.85 ABL1 (0.56) ABL1BCRLMNAALDH1A1SMN1; SMN2
SCHEMBL17507859 0.84 FGFR1 (0.49) ABL1BCRLMNAALDH1A1SMN1; SMN2
SCHEMBL30910334 0.84 FGFR1 (0.55) ABL1BCRLMNASMN1; SMN2FGFR1
SCHEMBL29246277 0.84 FGFR1 (0.55) ABL1BCRLMNASMN1; SMN2FGFR1
SCHEMBL30910343 0.81 FGFR1 (0.56) ABL1BCRFGFR1FGFR4MAPT
SCHEMBL29246282 0.81 FGFR1 (0.56) ABL1BCRFGFR1FGFR4MAPT
SCHEMBL3541053 0.81 NOTUM (0.58) FGFR1FGFR4NOTUMKCNH2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117865965-B Pyrrolopyrimidine-4-amine and pyrazolopyrimidine-4-amine derivatives, preparation method and application thereof 贵州省天然产物研究中心 2024-06-28 CN disclosed
US-20070203159-A1 Purine compounds UNIVERSITETET I OLSO (NO) 2007-08-30 US disclosed
US-20070203159-A1 Purine compounds UNIVERSITETET I OLSO (NO) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203159-A1 Purine compounds PNP, UMPS, TYMP ABL1 559/4885BCR 1842/4885LMNA 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.